Flow cytometry equipment compared from the manufacturers' own pages: what separates a conventional analyser from a spectral one, and why the best flow cytometer is the one whose detector configuration matches the panel you have already designed

A cytometer is chosen by the panel it has to run, and a panel designed after the instrument arrives is a panel constrained by somebody else's optical layout. This page reads four analysers on their manufacturers' own pages and says what each is built around, so the shortlist starts from the detection you need rather than from a brand.

manufacturer product pages read for this page on 11 September 2026
4 read
bandpass filters Beckman lists on the CytoFLEX V-B-R series page
13
the electronic records rule named on one of the four product pages
Part 11

Figures in this panel are what the manufacturers published on their own product pages on 11 September 2026, each linked in the sources below and recorded in this estate's claims ledger, plus the records rule one of them names. They are not prices: BioBricks publishes verified prices for synthesis services only, and none of these four publishes an instrument price.

The four, as their own pages describe them

  1. Cytek Aurora, full spectrum detection. Cytek presents the Aurora as a full spectrum instrument, with its own published material on enhanced small particle detection and on spectral analysis applied to cytometry. Read it as the spectral-first option: the design assumption is that you will unmix whole emission signatures rather than assign one filtered detector per dye.
  2. Beckman Coulter CytoFLEX, a configurable conventional analyser. Beckman's CytoFLEX page describes a violet-blue-red series activatable from four up to thirteen colours, listing thirteen bandpass filters by wavelength, with an optional plate loader for throughput and software tools for 21 CFR Part 11 environments. Read it as the conventional analyser you buy small and light up later.
  3. BD FACSymphony A5 SE, spectral or compensation on one instrument. BD describes the A5 SE as offering full visible spectrum coverage without filter changes while retaining the familiar compensation workflow, unmixing spectral data live in its acquisition software, with autofluorescence unmixing offered as a way to resolve difficult populations and an upgrade kit route from an existing A5. Read it as the option for a laboratory that wants spectral capability without abandoning its established workflow.
  4. Thermo Fisher Attune, acoustic focusing for throughput. Thermo's Attune family page leads on acoustic focusing, using sound waves rather than hydrodynamic focusing to align cells, claiming faster processing and higher sample throughput, across the NxT workhorse, the CytPix model with a high speed brightfield camera and image analysis, and the Xenith. Read it as the throughput-and-imaging option.
  5. Then decide sorting, containment and who runs it. An analyser and a sorter are different purchases with different rooms. A sorter generates aerosols and needs containment and a trained operator, which is why many laboratories buy an analyser and buy sorting as a service from a core facility.

The room decides more than the brochure does

Bench space, power, temperature, sheath and waste handling and a place for the computer are site requirements. A sorter adds containment, and in many buildings that is the constraint that chooses the instrument rather than any optical specification.

Ask for the site preparation document before the quotation is signed. Remedial work on a laboratory is slow and it is invariably charged to the project that discovered it.

Service is the recurring number

Cytometer service contracts are a significant annual cost and the response time in them is what decides whether a failure costs a day or a fortnight. Get the contract terms, the on-site response time and the loan instrument policy in writing per vendor.

Ask how long the platform has been sold and what the end of support position is. Instruments outlive software, and an analyser whose acquisition software no longer runs on a supported operating system is a problem that arrives without warning.

Buying against a core facility

If a core facility down the corridor runs the panel you need, the honest comparison is instrument purchase against hourly access, including the staff time an owned instrument consumes in quality control, cleaning and troubleshooting.

Owning makes sense when scheduling is the constraint or the work is continuous. For intermittent work, core access usually gives better instruments and better data for less money.

Antigen density flow cytometry, and the instrument's part in it

Antigen density is a question about how many molecules sit on a cell, and a cytometer answers it only when the measurement is anchored. That means calibration beads carrying a known number of fluorophore equivalents, a fluorophore whose brightness per antibody is known, and a detector configuration recorded so that today's median can be compared with last month's. The instrument's contribution is its sensitivity at the dim end, the detection threshold that separates a weakly positive population from the negative, which is set by the laser, the filter and the detector rather than by the stain.

A stim1 antibody and the partner that makes the channel

STIM1 senses store depletion and then clusters to open its channel partner, so a stim1 antibody is read as puncta after store depletion rather than as a level, and the partner belongs in the same image. It is an endoplasmic reticulum membrane protein, so the fraction matters, and the functional readout is calcium entry rather than either protein's abundance.

A ddr1 antibody and a receptor activated by collagen

DDR1 is a kinase activated by collagen rather than by a soluble ligand, so a ddr1 antibody is read with the matrix as part of the experiment, and activation is slow and sustained rather than transient. The receptor is shed, so an extracellular domain clone may report a soluble fragment, and the family relative shares kinase sequence which is the cross reactivity to check.

A vegfr3 antibody and the lymphatic reading

VEGFR3 marks lymphatic endothelium in adult tissue, so a vegfr3 antibody is used as a lymphatic marker and is read with a blood vessel marker to make the distinction. It is expressed on some tumour vasculature too, which is the caveat. The receptor is proteolytically processed, so the expected masses and the epitope position belong in the method.

An il13ra2 antibody and a decoy receptor

IL13RA2 binds its cytokine without signalling, acting as a decoy, and it is a tumour target because expression is restricted in normal tissue, so an il13ra2 antibody is hard to validate with normal controls that are negative by design. A positive and a negative line from the same panel are the minimum, and surface work needs a clone validated unpermeabilised.

A gpcr antibody, and why the class is difficult

A gpcr antibody faces the same three problems across the whole class: low surface density, multipass topology that hides linear epitopes, and large families with conserved regions, which is why so many published patterns did not survive knockout tissue. Knockout validation, a tagged construct or a labelled ligand are the three honest routes, and the datasheet should say which supports it.

A tlr3 antibody and an intracellular receptor

TLR3 signals from the endosome rather than the surface, so a tlr3 antibody used on unpermeabilised cells reads low even in a responsive line, and that is the biology rather than a failed stain. Function is read as the interferon response to a double stranded RNA analogue, which is the control that shows the pathway. Species differences in expression are substantial.

A zbp1 antibody and a sensor that triggers lytic death

ZBP1 senses nucleic acid duplexes and drives necroptosis, so a zbp1 antibody reports a sensor whose expression is interferon inducible, and an unstimulated control is what makes a positive readable. The downstream readout is the executioner kinase's phosphorylation rather than this protein's level, which is why the pair appears together in figures.

Common questions

What is the best flow cytometer?
The one whose laser and detector configuration runs the panel you need, in the room you have, with the service you can get. Of the four read here, two lead on spectral detection, one on configurable conventional detection and one on acoustic focusing for throughput, and those are genuinely different jobs.
Spectral or conventional flow cytometry equipment?
Spectral for large panels, for dyes with overlapping peaks and where sample autofluorescence is a problem. Conventional where panels are modest and the workflow is established. One instrument read here deliberately offers both workflows on the same machine.
How many detectors do I actually need?
Design the panel first, then count. Buying detectors you may use later is how laboratories end up with an instrument configured for someone else's experiment, and most platforms allow channels to be activated later anyway.
Do I need 21 CFR Part 11 tools?
Only if the data supports regulated work. One of the four read here names Part 11 tooling in its software on the product page; for a research laboratory that capability is usually cost without benefit.
What should the quotation include beyond the instrument?
Installation and qualification, the service contract, the sheath and waste handling, the computer and analysis software licences, and training. On a cytometer the service contract is a large recurring figure and it belongs in the comparison from the start.

Get a shortlist for your project

Free. We send a shortlist of vendors whose published prices and service scope fit what you described, built from the verified index on this site. We may email you about this enquiry and similar services from this site; opt out any time, including from the first message.

Browse by service class

Sources

Cite or embed this figure

The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.

Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/flow-cytometry-equipment/.

Embed this figure (plain HTML, no scripts)
median advertised gene synthesis price per base pair · the US research synthesis services market · August 2026

$0.11

Middle 50%$0.07 – $0.15
verified vendor service pages4

Source: BioBricks Synthesis Price Index

Get a vendor shortlistCompare synthesis prices